The Latest Breaking News from Verve

A renaissance is stirring in cholesterol treatment, and it could drive Merck, Novartis and other stocks higher, while delivering new choices for millions of patients.

Delicious and colourful, knowing how to grow peppers from seed will brighten up a south facing windowsill or vegetable patch for next to nothing

When they weren't splitting up on a monthly basis, The Verve made some fabulous records

I've reviewed chairs for years, but this is the one I'd recommend to most people working from home.

The Empire State Bastard riff-meister and Biffy Clyro guitarist has produced some of his best work with his latest solo album, Forgiveness & The Grain. He breaks down his otherworldly tone secrets, and explains what made The Verve’s Nick McCabe a guitar Jedi – and why the Pro Co Rat…

Are the pervasive plantshakes worth the hype?

John Orloff, co-creator of Masters of the Air, signs with UTA after success with A Mighty Heart and Legend of the Guardians. Masters of the Air, a sequel t...

Verve stock collapsed Tuesday after a sixth patient who received its cholesterol-lowering gene-editing treatment experienced side effects.

Looking to increase your protein intake? This is exactly what you need

Cathie Wood's ARK Innovation ETF isn't afraid to go against Wall Street and the S&P 500. But in some cases, the consensus agrees with the famed ETF manager.

Verve stock crashed Monday as safety concerns plagued its gene-editing approach to high cholesterol. VERV stock lost more than a third of its value.